Humans might be the most resilient species on Earth, but until recently, no one could explain how a small population survives the incredibly harsh conditions of the Tibetan Plateau – a lofty, oxygen-starved environment that towers 4.5 km above sea level.

Researchers say a major genomic study will provide answers for patients with unexplained kidney disease, and could lead to better treatments.

The Institute for Molecular Bioscience (IMB) has celebrated the graduations of its first PhD students from Serbia and Nepal, who investigated rare neurodegenerative disorders and diagnostic tools for dengue fever.

The Director of The University of Queensland’s Institute for Molecular Bioscience (IMB) will help steer a national initiative striving to double survival rates for people with brain cancer over the next decade.

In the “golden era” of antibiotic drug discovery – 1950 to 1970 – drug companies could afford to be choosy, selecting only the very best candidates for approval.As a result, many potent antibiotics did not make the cut for development and were abandoned. Given the current crisis in antibiotic discovery, the time is right to revisit many of these potentially invaluable molecules in search of antibiotic scaffolds with novel modes of action.

An antibiotic overlooked since its discovery 40 years ago could help develop new drugs against life-threatening infections caused by some of the world’s most dangerous superbugs.

You know the drill. A picnic in the park, a walk in the bush or a barbecue with friends and family – all perfect summer activities that can be ruined by annoying flies that never leave you alone.

So why do they do it and what do they want?

Did you know that when you take certain genetic tests, the company can make money by on-selling your data to other businesses?

Now new blockchain-based marketplaces could give individuals control over access to their encrypted DNA data, and the ability to sell it to research companies for their own profit.